Log in
/
Register
Home
Overview
Upload / Manage Data
Browse / Search Studies
Analyze Studies
Tutorials
FAQ
Data Repository
Overview
Upload / Manage Studies
Browse / Search Studies
Analyze Studies
Data Sharing Policy
Tutorials
FAQ
Databases
Overview
Metabolite Database
Human Metabolome Gene/Protein Database (MGP)
RefMet: Reference List of Metabolite Names
External Metabolomics Databases (Links)
Protocols
Overview
General Protocols
Study-specific Protocols
Tools
Overview
Load and analyze your own dataset
Analyze Studies
MS Searches
Structure drawing
REST Service
External Tools (Links)
About
Overview
Publishing Partners
How to Cite
How to Link
Terms of Use
Personnel
Contact
Sitemap
Search
Keyword Search
Advanced Searches
Return to study ST000422 main page
Show: (1)
HMDB and KEGG pathways
(2)
REACTOME pathways
containing these metabolites
Select
Metabolite Name
Metabolite Id
Refmet Name
Ret. Index
Quant. m/z
Analysis Display
Anandamide (20:2, n-6)
ME142424
Eicosadienoyl-EA
-
-
HILIC POSITIVE ION MODE
Anandamide (20:5, n-3)
ME142515
Eicosapentenoyl-EA
-
-
HILIC POSITIVE ION MODE
N-arachidonoyl D-serine
ME143573
N-Arachidonoyl D-serine
-
-
HILIC POSITIVE ION MODE
pentanamide
ME143881
Pentanamide
-
-
HILIC POSITIVE ION MODE
12-amino-dodecanoic acid
ME146186
12-Aminododecanoic acid
-
-
Reversed phase POSITIVE ION MODE
Adipamide
ME147948
Adipamide
-
-
Reversed phase POSITIVE ION MODE
Anandamide (18:3, n-6)
ME147392
gamma-Linolenoyl-EA
-
-
Reversed phase POSITIVE ION MODE
Arachidonoylmorpholine
ME147274
Arachidonoylmorpholine
-
-
Reversed phase POSITIVE ION MODE
Arachidonoylmorpholine + 12.806118
ME147293
Arachidonoylmorpholine
-
-
Reversed phase POSITIVE ION MODE
dodecanamide
ME146674
Dodecanamide
-
-
Reversed phase POSITIVE ION MODE
Linoleamide
ME147247
Linoleamide
-
-
Reversed phase POSITIVE ION MODE
(-)N-(1R-methyl-propyl) arachidonoyl amine
ME147278
N-(1R-Methyl-propyl) arachidonoyl amine
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)icosanamide
ME147269
Eicosanoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)oleamide
ME147568
Oleoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide
ME147306
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 14.244078
ME147554
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)palmitamide + 14.481297
ME147618
Palmitoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-(2-hydroxyethyl)stearamide
ME147511
Stearoyl-EA
-
-
Reversed phase POSITIVE ION MODE
N-arachidonoyl D-serine
ME146411
N-Arachidonoyl D-serine
-
-
Reversed phase POSITIVE ION MODE
N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine
ME147179
N-Ethyl N-(2-hydroxy-ethyl) arachidonoyl amine
-
-
Reversed phase POSITIVE ION MODE
N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine + 1...
ME147224
N-Ethyl N-(2-hydroxy-ethyl) arachidonoyl amine
-
-
Reversed phase POSITIVE ION MODE
octadecanamide
ME147436
Stearamide
-
-
Reversed phase POSITIVE ION MODE
Oleamide
ME147417
Oleamide
-
-
Reversed phase POSITIVE ION MODE
pentanamide
ME145523
Pentanamide
-
-
Reversed phase POSITIVE ION MODE
pentanamide + 4.2868834
ME145931
Pentanamide
-
-
Reversed phase POSITIVE ION MODE
Stearamide
ME147579
Stearamide
-
-
Reversed phase POSITIVE ION MODE
(Z)-N-(2-hydroxyethyl)icos-11-enamide
ME147381
11Z-Eicosaenoyl-EA
-
-
Reversed phase POSITIVE ION MODE
UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
Terms of use
Site map
Contact
NMDR Personnel